Australia markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
21.85+0.16 (+0.74%)
As of 01:05PM EDT. Market open.
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-167,825
-167,825
143,403
507,364
214,310
Depreciation & amortisation
-
26,143
32,662
11,004
2,962
Deferred income taxes
-
7,608
831
-7,840
-1,398
Stock-based compensation
-
42,922
32,640
15,882
8,157
Change in working capital
-
2,841
2,005
-2,676
-91,451
Accounts receivable
-
2,388
68,638
42,300
-178,480
Accounts payable
-
-6,896
-25,339
-12,206
22,617
Other working capital
-
4,796
224,745
514,733
105,498
Other non-cash items
-
6,391
4,902
1,139
417
Net cash provided by operating activities
-
27,003
253,520
538,577
140,628
Cash flows from investing activities
Investments in property, plant and equipment
-
-22,207
-28,775
-23,844
-35,130
Acquisitions, net
-
-399
-172,679
-61,868
-3,971
Purchases of investments
-
-491,914
-432,982
-730,490
-324,359
Sales/maturities of investments
-
552,643
372,710
269,591
37,014
Net cash used for investing activities
-
38,898
-261,314
-546,548
-326,438
Cash flows from financing activities
Debt repayment
-
-4,996
-1,067
-11
0
Common stock issued
-
0
0
89,475
246,190
Common stock repurchased
-
-25,060
-74,337
0
0
Other financing activities
-
-17,732
-1,768
-4,145
-62
Net cash used provided by (used for) financing activities
-
-47,785
-77,141
85,405
261,251
Net change in cash
-
17,967
-85,388
77,468
75,461
Cash at beginning of period
-
79,506
164,894
87,426
11,965
Cash at end of period
-
97,473
79,506
164,894
87,426
Free cash flow
Operating cash flow
-
27,003
253,520
538,577
140,628
Capital expenditure
-
-22,207
-28,775
-23,844
-35,130
Free cash flow
-
4,796
224,745
514,733
105,498